Irreversible enzyme inhibitors. LXXXIX. candidate active-site-directed irreversible inhibitors of dihydrofolic reductase. X. derivatives of 2-amino-5-benzamidopropyl-4-pyrimidinol

Since 2-amino-5-benzamidopropyl-6-methyl-4-pyrimidinol (VII) was a reasonably good reversible inhibitor of dihydrofolic reductase, the benzamido group was substituted with p-bromomethyl (XVIIa), m-bromomethyl (XVIIIa), and p-bromoacetyl (XIXa) groups; these compounds, and the corresponding 6-phenylpyrimidines, were synthesized from the proper 2-amino-5-aminopropyl-4-pyrimidinol (V) by devising methods that were compatible with the high reactivity of the halogen. Compounds XVII-XIX showed in-activation of dihydrofolic reductase; the fact that p-nitrobenzyl bromide inactivated the enzyme as rapidly as XVII and XVIII and phenacyl bromide inactivated the enzyme as rapidly as XIX indicated that these inactivations proceeded by a random bimolecular mechanism and not the desired active-site-directed mechanism.     

Irreversible enzyme inhibitors. LXXXV. On the mode of pyrimidine binding of 5-alkyl and 5-arylpyrimidines to dihydrofolic reductase

A series of 5-isoamyl- and 5-(p-chlorophenyl)pyrimidines substituted with amino, alkylamino, mercapto, benzyloxy, hydroxy, or hydrogen at the 2- and 4-positions and with amino or methyl at the 6-position have been synthesized for evaluation of the mode of pyrimidine binding to dihydrofolic reductase. The studies were performed in order to determine where a bulky group could be placed on the pyrimidine ring that would still allow good binding; such studies are essential to find a suitable position for placement of a covalent forming group for design of active-site-directed irreversible inhibitors. Two classes of candidate compounds have emerged for further study as irreversible inhibitors, namely, 2-amino-4-mercapto-6-(p-bromoacetamidophenylalkyl)-pyrimidines and 2,4-diamino-6-(p-bromoacetamidophenylalkyl)aminopyrimidines having a group such as phenyl, phenylbutyl or isoamyl at the 5-position that can give strong hydrophobic bonding to the enzyme.     

Irreversible enzyme inhibitors. CXI. Candidate active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-l-phenyl-s-triazines. V.

Condensation of 5-(p-nitrophenyl)-2-pentanone with phenylbiguanide hydrochloride (V) gave a 2-methyl-2-(p-nitrophenylpropyl)-1,2-dihydro-s-triazine (IX); hydrogenation of the nitro group to amino followed by bromoacetylation afforded the candidate irreversible inhibitor of dihydrofolic reductase, namely, 2-(p-bromoacetamidophenylpropyl)-4,6-diamino-1,2-dihydro-2-methyl-s-triazine hydrochloride (VIII). Similarly, the o, m, and p-isomers of 5-nitrophenoxy-2-pentanone were converted to the corresponding 2-(bromoacetamidophenoxypropyl)-1,2-dihydro-s-triazines (XI). The four candidate irreversible inhibitors were evaluated on the dihydrofolic reductases from pigeon liver, Walker-256 rat tumor, and L-1210/FR8 mouse leukemia. Only VIII was an irreversible inhibitor; VIII slowly inactivated the L-121-/FR8 mouse leukemia enzyme with a half-life of 2–3 hours at 37°, but VIII showed no inactivation of the other two dihydrofolic reductases—a species specific inactivation.     

Irreversible enzyme inhibitors. XC. candidate active-site-directed irreversible inhibitors of thymidylate synthetase. I. 2-amino-5-(benzenesulfonamidopropyl)-6-methyl-4-pyrimidinol with substituents on the benzene ring

2-Amino-5-[p- (bromoacetamidomethyl)benzenesulfonamidopropyl]-6-methyl-4-pyrimidinol (XV) was synthesized by acylation of 2-amino-5-aminopropyl-6-methyl-4-pyrimidinol (III) with p-cyanobenzenesulfonyl chloride followed by catalytic reduction and reaction of the resultant aminomethyl group with p-nitrophenyl bromoacetate. A second irreversible inhibitor of thymidylate synthetase, namely 2-amino-5-[p-(bromoacetyl)benzene-sulfonamidopropyl]-6-methyl-4-pyrimidinol (XVI), was synthesized by acylation of in with p-acetylbenzenesulfonyl chloride followed by bromination. Both XV and XVI were good reversible inhibitors of thymidylate synthetase and inactivated the enzyme when the candidate compound was incubated with the enzyme. Iodoacetamide, which does not form a complex with enzyme, could inactivate thymidylate synthetase almost as well as XV; therefore it appears that XV inactivated the enzyme by a random bimolecular mechanism rather than by the desired active-site-directed mechanism via an enzyme-inhibitor complex. Similar conclusions were reached with XVI since phenacyl bromide could inactivate the enzyme somewhat more rapidly than XVI.     

Synthesis of 6-substituted pyrimidines by the wittig reaction. III . Via 2-amino-4-hydroxy-5-phenylbutyl-6-pyrimidylmethyl triphenyl phosphonium bromide

2-Amino-6-bromomethyl-5-phenylbutyl-4-pyrimidinol (IV) smoothly alkylated triphenyl phosphine, resulting in a 95% yield of the phosphonium salt (V). This Wittig reagent (V) readily condensed with p-nitrobenzaldehyde, p-nitrocinnamaldehyde, or cinnamalde-hyde in N,N-dimethylformamide to give the 6-(p-nitrostyryl) (X), 6-(p-nitrophenyl-1,3-butadien-1-yl) (VIH), and 6-(phenyl-1,3-butadien-1-yl) (IX) pyrimidinols in 72, 67 and 44% yields, respectively. Catalytic reduction of VIII and IX afforded the corresponding 6-(p-aminophenylethyl) (XII) and 6-(p-aminophenylbutyl) (XI) 4-pyrimidinols.     

Pyrimidine derivatives and related compounds. A novel synthesis of pyrimidines,pyrazolo[4,3-d]pyrimidines and isoxazolo[4,3-d] pyrimidine

Benzoylacetonitrile (II) reacted with trichloroacetonitrile (III) to yield the β-amino-β-trichloromethylacrylonitrile IV. Compound IV reacted with hydrazine hydrate to yield 5-amino-4-cyano-3-phenylpyrazole (V) and with 2-aminopyridine to yield the aminopyridine derivative VIII (cf., Chart I). Compound IV reacted with III to yield 2,4-bis(trichloromethyl)-5-cyano-6-phenylpyrimidine (I) which could be converted into a variety of pyrazolo[4,3-d]pyrimidine derivatives by treatment with hydrazine hydrate under a variety of different experimental conditions (cf., Chart II).     

Irreversible enzyme inhibitors. XCI. candidate active-site directed irreversible inhibitors of thymidylate synthetase. II. 2-amino-6-methyl-5-(p-tolylsulfonamidopropyl)-4-pyrimidinols with N-substituents on the sulfonamide moiety

Three derivatives of 2-amino-6-methyl-5-(p-tolylsulfonamidopropyl)-4-pyrimidinol (I) with N - substituents on the sulfonamide group, namely bromoacetamidopropyl (XVI), m-bromoacetamidobenzyl (XXIVa), and p-bromoacetamidobenzyl (XXIVb), were synthesized as candidate active-site-directed irreversible inhibitors of thymidylate synthetase. The bromoacetamidopropyl derivative, (XVI), the p-bromoacetamidobenzyl derivative (XXIVb), and iodoacetamide showed irreversible inhibition of thymidylate synthetase, but XXIVa did not. Since iodoacetamide did inactivate the enzyme, but XXIVa did not, it cannot be ascertained whether XXIVb and XVI inactivate the enzyme by a random bimolecular mechanism or by the active-site-directed mechanism without evaluation of additional candidate inhibitors. Two synthetic routes were employed. The key intermediates for the bromoacetamidobenzyl sulfonamides (XXIV) were the corresponding nitrobenzyl sulfonamides (XXI); the latter were best prepared by reductive alkylation of 2-amino-5-aminopropyl-6-methyl-4-pyrimidinol (XXV) with a nitrobenzaldehyde followed by tosylation. The key intermediate for XVI was a toluenesulfonamide with a carbobenzoxyaminopropyl substituent on the nitrogen (XIV); the latter was synthesized via N-carbobenzoxy-N'-tosyl-1,3-diaminopropane (XI).     

Irreversible enzyme inhibitors. LXXXI. Further observations on the mode of binding of the anilino moiety of 2-amino-5-(anilinopropyl)-6-methyl-4-pyrimidinol to dihydrofolic reductase and thymidylate synthetase

Replacement of phenyl group of 2-amino-5-(anilinopropyl)-6-methyl-4-pyrimidinol (III) by benzyl (XI) led to a large loss in binding to both dihydrofolic reductase and thymidylate synthetase; the binding by XI returned when the protonated benzylamino group was N-acetylated to XII, which removes the charge at pH 7.4 and changes the ground-state conformation of the benzene ring. Replacement of the benzyl group of the acetamide, XII, with the polar 2-, 3-, or 4-, picolyl groups also led to a loss in binding. Substitution of p-fluoro or m-trifluoromethyl on the anilino group of III, or replacement of the anilino of III by 3-pyridylamino, gave little - if any - enhancement in binding to the enzymes.     

Irreversible enzyme inhibitors. XCIV. inhibition of dihydrofolic reductase with derivatives of 2,6-diaminopurines

In order to gain additional information on the hydrophobic bonding region of dihydrofolic reductase, some derivatives of 2, 6-diaminopurine with aryl or aralkyl groups at the N⁶, C⁸ and N⁹-positions were investigated as inhibitors. Since none of the six compounds gave an increment in binding over the parent 2, 6-diaminopurine, hydrophobic bonding to dihydrofolic reductase could not be detected with this ring system. Furthermore, 2, 6-diaminopurine bridged from its 8-position with methylene groups to the amino group of p-aminobenzoic acid also failed to show an increment in binding. The 8-substituted 2, 6-diaminopurines were synthesized by base-catalyzed cyclodehydration of the appropriate 5-acylamido-2, 4, 6-triaminopyrimidines; the latter compounds were readily prepared by selective acylation of tetraaminopyrimidine.     

Studies on the syntheses of azole derivatives. Part VII. Syntheses of 1 -phenyl-Δ2-1,2,4-triazolin-5-one derivatives [studies on the syntheses of heteroeyclic compounds. CD XI]

Bromination of 3-methyl-1-phenyl-Δ²-1,2,3-lriazolin-5-one (II) and its 4-phenyl derivative III afforded the corresponding I-(p-Bromophenyl) derivatives IV and V, respectively. (Chlorination of the 4-phenyl derivative III gave I-(P-chlorophenyl) derivative VI. In addition, 3-N-subsuituted-carhamoyl-1,2,4-triazolin-5-ones(XII, XIII, and XIV) were synthesized by the Schotten-Baumann reaction of 3-carboxy-1-phenyl-Δ²-1,2,4-triazolin-5-one (XI) with various amines.     

Benzomorphan related compounds. IV. The stevens rearrangement of a trimethoxybenzyl-1,2,5,6-tetrahydropyridinium salt

The potassium hydroxide-induced (Stevens) rearrangement of 1,3,4-trimethyl-1-(3,4,5-trimethoxybenzyl)-1,2,5,6-tetrahydropyridinium chloride (I) gives the desired 1,3,4-trimethyl-2-(3,4,5-trimethoxybenzyl)-1,2,5,6-tetrahydropyridine (III) and the Hofmann elimination product, N-methyl-N-(3,4,5-trimethoxybenzyl)-2,3-dimethyl-2,4-pentadienamine (II). In the presence of ethereal phenyllithium, the salt I undergoes rearrangement giving the expected tetrahydropyridine III in about 17% yield and four other products, N-(3,4,5-trimethoxybenzyl)methylamine (VI), 1,3,4-trimethyl-2-(6-methyl-2,3,4-trimethoxyphenyl)-1,2,5,6-tetrahydropyridine (IV), 1,3,3-trirnethyl-2-(3,4,5-trimethoxyphenyl)-4-rnethylenepiperidine (V) and 1,3,4-trimethyl-4-(3,4,5-trimethoxybenzyl)-1,4,5,6-tetrahydropyridine (VII), the latter being the 1,4-Stevens rearrangement product which cyclizes easily to β-2′,3′,4′-trimethoxy-2,5,9-trimethyl-7,8-benzomorphan (VIII). Their structures have been proved both by analytical and spectral data. A possible route for VIII and its stereochemical aspects are discussed.     

Synthesis of heterocycles. Part II. New routes to acetylthiadiazolines and alkylazothiazoles

Methylglyoxalyl chloride arylhydrazones (III) react with an ethanolic solution of thiourea to give 2-amino-4-methyl-5-arylazothiazoles (XII) instead of the expected 2-acetyl-4-aryl-5-imino-Δ²-1,3,4-thiadiazolines (V) which were obtained from III and potassium thiocyanate. 3-Thiocyanato-2,4-pentanedione (IV) coupled with diazotized anilines to give V. The postulated routes to formation of V and XII from III are given. Nitrosation of V gave the corresponding N-nitroso derivatives (VI) which decomposed upon refluxing in dry xylene to give 2,4-disubstituted-Δ²-1,3,4-thiadiazolin-5-ones (VII). Boiling of either V or VI with hydrochloric acid gave the hydrochloride salt (VIII). The thiadiazolines V gave the respective N-acyl derivatives (IX) and (X) with acetic anhydride and benzoyl chloride in pyridine.     

Photooxygenation of 5-aryl-2,4-diaminopyrimidines leading to 4-amino-1,3,5-triazin-2-yl ketones and,in the presence of sodium borohydride,to 5,6-dihyro-4(3H)-pyrimidinones

The photosensitized oxygenation of 5-aryl-2,4-diaminopyrimidines 1 in protic solvent led to the formation of the new 4-amino-1,3-5-triazin-2-yl ketones 2 in high yields. The structures of 2 were elucidated by spectroscopical means, especially by ¹³C-NMR and UV data. Photooxygenation of 2,4-diamino-5-(p-chlorophenyl)-6-ethylpyrimidine 1a under reductive conditions, e.g. In the presence of excess NaBH₄, gave 2-amino-5-(p-chlorophenyl)-t-6-ethyl-5,6-dihydro-r-5-hydroxy-4(3H)-pyrimidinone ( 4a ), the structure of which was determined by X-ray analysis. In the proposed mechanisms for both types of reactions, the dipolar ion 5 is assumed to be a common intermediate. For the new efficient synthesis of 1,3,5-triazines from 2,4-diaminopyrimidines, a 5-aryl substituent seems to be essential.     

Studies on the syntheses of analgesics. Part XXXII. An alternative synthesis of 1,2,3,4,5,6-Hexahydro-8-hydroxy-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazoeine [Studies on the syntheses of heterocyclic compounds. Part CDLXXX]

Bischler-Napieralski reaction of the amides (VIII and IX), derived from the 3-methyl-3-pentenylamine (III) with the phenylacetic acid derivatives (V ～ VII), gave the 5,6-dihydropyridines (XII and XIII), which were reduced, followed by N-benzylation, to afford the 1,2,5,6-tetrahydropyridines (XIX ～ XXI). Grewe-type cyclization of these compounds gave 3-benzyl-3-benzazocine (II), which was already converted into pentazocine (Ic). Moreover, the 1,2,5,6-tetrahydropyridines (XIX ～ XXI) were also obtained from the 2-benzylidene-1,2,5,6-tetrahydropyridine (XVII ～ XVIII) from the N-benzylamine (IV) of III via the amides (X and XI).     

On the mechanism of hydrolysis of the triazolobenzodiazepine,triazolam. Spectroscopic study

The hydrolysis of 8-chloro-6-(2′-chlorophenyl)-1-methyl-4H[1,2,4]triazolo[4,3-a][1,4]benzodiazepine (Triazolam) at room temperature, involves a reversible mechanism. The intermediate is a protonated species and the final product is the ring-opened compound resulting from the reversible scission of the imine bond. The two compounds were determined simultaneously as a function of pH with pmr and cmr spectrometry. Spectral data of the benzophenone derivative II (ir, cmr, pmr) are reported.     

Thermische Umwandlung von Phenyl-penta-2,4-dienyläthern in 4-[Penta-2,4-dienyl]-phenole als Beispiel für [5,5]-sigmatropische Umlagerungen. Vorläufige Mitteilung

The reaction between phenol and trans penta-2,4-dienyl chloride gave trans penta-2,4-dienyl Phenyl ether (I), whereas with a mixture of sorbyl chloride and 1-methylpenta-2,4-dienyl chloride, pure trans, trans hexa-2,4-dienyl phenyl ether (IV) and trans 1-methylpenta-2,4-dienyl phenyl ether (V) were obtained. The ether I gave, on heating in dilute solution at 185°, 4-(penta-2,4-dienyl)-phenol (III) as the main product, and also some 2-(2-vinylallyl)-phenol (II). The ether IV provided, on heating at 165°, in addition to the ortho CLAISEN rearrangement product VI, mainly a mixture consisting of 94% 4-(1-methylpenta-2,4-dienyl)-phenol (VIII) and only 6% 4-(hexa-2,4-dineyl)-phenol(IX). The latter product (IX) was the only para isomer produced on heating ether V, but in addition 22% of the ortho rearrangement product VII was formed. The migrations I → III, IV → VIII, and V → IX, proceeding through a ten membered transition state, are the first [5,5] sigmatropic rearrangements described.     

Reaction of 6-phenyl-2-(p-toluenesulfonyl)-3(2H)pyridazinone with grignard reagents

6-Phenyl-2-(p-toluenesulfonyl)-3(2H)pyridazinone (I) reacted with Grignard reagents to give 5-substituted 4,5-dihydro-3(2H)pyridazinones II and two types of dihydropyridazines, III and IV. The ratio of II, III, and IV was sensitively dependent on the reaction conditions. Further, by quenching the reaction mixture with alcohol, the ring-opened product VII was mainly isolated.     

The reaction of aroylhydrazines with N-phenylsulfonylarenehydrazonoyl chlorides. A route to substituted 4-amino-(4H)-1,2,4-triazoles and 1,3,4-oxadiazoles

Treatment of N-phenylsulfonylarenehydrazonoyl chlorides (II) with equivalent amounts of aroylhydrazines (III) in ethanol gave 3,5-diaryl-4-phenylsulfonylamino-1,2,4-triazoles (IV). Reaction of II with two equivalents of III in tetrahydrofuran gave 2,5-diaryl-1,3,4-oxadiazoles (V), in addition to IV. Addition of triethylamine to II or its mixture with III yielded only the tetrazenes (VIII). The possible pathways leading to IV-V and VIII are discussed. J. Chem. Soc., 14, 1089 (1977)     

Brominated trimetrexate analogues as inhibitors of pneumocystis carinii and toxoplasma gondii dihydrofolate reductase

Five previously undescribed trimetrexate analogues with bulky 2′-bromo substitution on the phenyl ring were synthesized in order to assess the effect of this structure modification on dihydrofolate reductase inhibition. Condensation of 2-[2-(2-bromo-3,4,5-trimethoxyphenyl)ethyl]-1,l-dicyanopropene with sulfur in the presence of N,N-diethylamine afforded 2-amino-5-(2′-bromo-3′,4′,5′-trimethoxybenzyl)-4-methyl-thiophene-3-carbonitrile ( 15 ) and 2-amino-4-[2-(2′-bromo-3′,4′,5′-trimethoxyphenyl)ethyl]thiophene-3-car-bonitrile ( 16 ). Further reaction with chloroformamidine hydrochloride converted 15 and 16 into 2,4-diamino-5-(2′-bromo-3′,4′,5′-trimethoxybenzyl)-4-methylthieno[2,3-d]pyrimidine ( 8a ) and 2,4-diamino-4-[2-(2′-bromo-3′,4′,5′-trimethoxyphenyl)ethylthieno[2,3-d]pyrimidine ( 12 ) respectively. Other analogues, obtained by reductive coupling of the appropriate 2,4-diaminoquinazoline-6(or 5)-carbonitriles with 2-bromo-3,4,5-trimethoxyaniline, were 2,4-diamino-6-(2′-bromo-3′,4′,5′-trimethoxyanilinomethyl)-5-chloro-quinazoline ( 9a ), 2,4-diamino-5-(2′-bromo-3′,4′,5′-trimethoxyanilinomethyl)quinazoline ( 10 ), and 2,4-diamino-6-(2′-bromo-3′,4′,5′-trimethoxyanilinomethyl)quinazoline ( 11 ). Enzyme inhibition assays revealed that space-filling 2′-bromo substitution in this limited series of dicyclic 2,4-diaminopyrimidines with a 3′,4′,5′-trimethoxyphenyl side chain and a CH₂, CH₂CH₂, or CH₂NH bridge failed to improve species selectivity against either P. carinii or T. gondii dihydrofolate reductase relative to rat liver dihydrofolate reductase.     

Studies on the syntheses of heterocyclic compounds. CDXCI pyrimidine derivatives V. Abnormal condensation products of 4-amino-6-chloro-2-methoxypyrimidine with p-nitrobenzenesulfonyl chloride

Condensation of 4-amino-6-chloro-2-methoxypyrimidine (I) with p-nitrobenzenesulfonyl chloride (II) gave, in addition to 6-chloro-2-methoxy-4-(p-nitrobenzenesulfonamido)pyrimidine (III), two abnormal by-products, the structures of which were assigned as 1 -[2-methoxy-4-(p-nitrobenzenesulfonamido)pyrimidine-6-yl]pyridinium N,N-betaine (IV) and N-(p-nitrobenzene-sulfonyl)-β-ureido-β-pyridinium acrylamide N,N-betaine (V).